Increased Matrix Metalloproteinases in Cerebrospinal Fluids of Patients With Major Depressive Disorder and Schizophrenia
Open Access
- 16 July 2020
- journal article
- research article
- Published by Oxford University Press (OUP) in International Journal of Neuropsychopharmacology
- Vol. 23 (11) , 713-720
Abstract
Background: Chronic inflammation of the brain has a pivotal role in the pathophysiology of major depressive disorder (MDD) and schizophrenia (SCZ). Matrix metalloproteinases (MMPs) are extracellular proteases involved in pro-inflammatory processes and interact with interleukin-6, which is increased in the cerebrospinal fluid (CSF) of patients with MDD and SCZ. However, MMPs in the CSF in patients with MDD and SCZ remain unclear. Therefore, we compared MMPs in the CSF of patients with MDD and SCZ with those of healthy controls (HC).Methods: Japanese patients were diagnosed with DSM-IV-TR and clinical symptoms were assessed with the Hamilton Rating Scale for Depression for MDD and the Positive and Negative Syndrome Scale for SCZ. CSF was obtained from MDD (n = 90) and SCZ (n = 86) and from age- and sex-matched HC (n = 106). The levels of MMPs in CSF were measured with multiplex bead-based immunoassay.Results: The levels of MMP-2 in CSF were higher in both MDD and SCZ than HC and were positively correlated with clinical symptomatic scores in MDD, but not in SCZ. Regardless of diagnosis, the levels of MMP-2, -7, and -10 were positively correlated with each other, and the levels of MMP-7 and -10 were higher in MDD, but not in SCZ, compared with HC.Conclusion: Increased CSF levels of MMP-2 in MDD and SCZ may be associated with brain inflammation. State-dependent alteration of MMP-2 and activation of cascades involving MMP-2, -7, and -10 appeared to have a role in the pathophysiology of MDD.Keywords
Funding Information
- Japan Society for the Promotion of Science (18K15534, 18H02756, 18K07620)
- Japan Agency for Medical Research and Development (18dk0307081h0001, 18dm0107100h0003, 18dk0307062h0003)
- Takeda Science Foundation
- SENSHIN Medical Research Foundation
This publication has 55 references indexed in Scilit:
- The neuroinflammation marker translocator protein is not elevated in individuals with mild-to-moderate depression: A [11C]PBR28 PET studyBrain, Behavior, and Immunity, 2013
- The Role of Microglia and Matrix Metalloproteinases Involvement in Neuroinflammation and GliomasJournal of Immunology Research, 2013
- Matrix metalloproteinase-2 or -9 deletions protect against hemorrhagic transformation during early stage of cerebral ischemia and reperfusionNeuroscience, 2012
- Matrix Metalloproteinase-2 and -9 Secreted by Leukemic Cells Increase the Permeability of Blood-Brain Barrier by Disrupting Tight Junction ProteinsPLOS ONE, 2011
- Matrix Metalloproteinases Are Associated With Increased Blood–Brain Barrier Opening in Vascular Cognitive ImpairmentStroke, 2011
- Spontaneous and cytokine induced expression and activity of matrix metalloproteinases in human colonic epitheliumClinical and Experimental Immunology, 2008
- Matrix metalloproteinases MMP2 and MMP9 are upregulated by noradrenaline in the mouse neuroendocrine hypothalamusEuropean Journal of Neuroscience, 2008
- Microglial Activation and Matrix Protease Generation During Focal Cerebral IschemiaStroke, 2007
- Matrix Metalloproteinase-2 Plays a Critical Role in the Pathogenesis of White Matter Lesions After Chronic Cerebral Hypoperfusion in RodentsStroke, 2006
- The role of matrix metalloproteinase 7 in innate immunityImmunobiology, 2004